Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.

Journal of virology - 1 Dec 2000

Matteucci D, Poli A, Mazzetti P, Sozzi S, Bonci F, Isola P, Zaccaro L, Giannecchini S, Calandrella M, Pistello M, Specter S, Bendinelli M

Abstract excerpt

Attempts at vaccine development for feline immunodeficiency virus (FIV) have been extensive, both because this is a significant health problem for cats and because FIV may be a useful vaccine model for human immunodeficiency virus. To date, only modest success, producing only short-term protection, has been achieved for vaccine trials in controlled laboratory settings. It is unclear how relevant such experiments...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Cats

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Immunodeficiency Virus, Feline

Share to Phylogeny

Share to Prevalence

Share to Vaccination

Share to Viral Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 11069985
DOI: 10.1128/jvi.74.23.10911-10919.2000
PMCID: PMC113170

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.PMID 11069985Read ↗

Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected catsSemantic proximity Read ↗

Sequence variation of the feline immunodeficiency virus genome and its clinical relevance.Semantic proximity Read ↗

Dual-subtype FIV vaccine (Fel-O-Vax® FIV) protection against a heterologous subtype B FIV isolateSemantic proximity Read ↗

Lessons from the cat: development of vaccines against lentiviruses.Semantic proximity Read ↗

Evaluating Vaccine-Induced Immunity in Domestic Cats: Insights from a Large-Scale Study in ChinaSemantic proximity Read ↗

The challenge for the next generation of feline calicivirus vaccines.Semantic proximity Read ↗

Recombinant feline coronaviruses as vaccine candidates confer protection in SPF but not in conventional catsSemantic proximity Read ↗

Cats are protected against feline immunodeficiency virus infection following vaccination with a homologous AP-1 binding site-deleted mutant.Semantic proximity Read ↗

Natural Exposure to Feline Leukaemia Virus (FeLV) Infection in Owned and Group-Housed Rescue Cats and Diagnosis of FeLV InfectionSemantic proximity Read ↗

Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env.Semantic proximity Read ↗

An effectively protective VLP vaccine candidate for both genotypes of feline calicivirus.Semantic proximity Read ↗

[Yearly booster vaccine against feline calicivirus (FCV) for high risk cases].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.